Lessons for COVID-19 Immunity from Other Coronavirus Infections

Cited by (319)

Items 201–300 of 319

1. Seroprevalence and dynamics of anti-SARS-CoV-2 antibodies: a longitudinal study based on patients with underlying diseases in Wuhan
   Jin Yang, Libing Ma, Li Guo, Ting Zhang, Zhiwei Leng, Mengmeng Jia, Fangyuan Chen, Weiran Qi, Xingxing Zhang, Qing Wang et al. · 2022 · Respiratory Research
2. Prospects of animal models and their application in studies on adaptive immunity to SARS-CoV-2
   Xiaohui Wei, Na Rong, Jiangning Liu · 2022 · Frontiers in Immunology
3. Symptomatic MERS-CoV infection reduces the risk of future COVID-19 disease; a retrospective cohort study
   Aiman El‐Saed, Fatmah Mahmoud Othman, Henry Baffoe-Bonnie, Rawabi Almulhem, Muayed Matalqah, Latifah Alshammari, Majid M. Alshamrani · 2023 · BMC Infectious Diseases
4. The comprehensive insights into the B-cells-mediated immune response against COVID-19 infection amid the ongoing evolution of SARS-CoV-2
   Manish K. Dhawan, Nanamika Thakur, Manish Kumar Sharma, Ali Ahmed Rabaan · 2025 · Biomedicine & Pharmacotherapy
5. Inflammatory pathways and potential therapies for COVID-19: A mini review
   Areeg M. Dabbish, Nouran Yonis, Mohamed Salama, Musthafa Mohamed Essa, M. Walid Qoronfleh · 2021 · European Journal of Inflammation
6. SARS-CoV-2 seroprevalence and antibody trends in vaccinated, multi-ethnic healthcare employees
   Beh C.C. · 2021 · Tropical biomedicine
7. Modelling the Effect of the Interaction between Vaccination and Nonpharmaceutical Measures on COVID-19 Incidence
   Atsegine Canga, Gorka Bidegain · 2022 · Global Health
8. Salmonella-mediated oral delivery of multiple-target vaccine constructs with conserved and variable regions of SARS-CoV-2 protect against the Delta and Omicron variants in hamster
   Khristine Kaith S. Lloren, Vijayakumar Jawalagatti, Chamith Hewawaduge, Chandran Sivasankar, Jiyoung Park, John Hwa Lee · 2023 · Microbes and Infection
9. Airborne or droplet – is it possible to say?
   Evonne T Curran · 2020 · Journal of Hospital Infection
10. COVID-19 Seroprevalence among Healthcare Workers of a Large COVID-19 Hospital in Rome Reveals Strengths and Limits of Two Different Serological Tests
    Giuseppe Vetrugno, Daniele Ignazio La Milia, Floriana D’Ambrosio, Marcello Di Pumpo, Roberta Pastorino, Stefania Boccia, Rosalba Ricci, Fabio De‐Giorgio, Michela Cicconi, Federica Foti et al. · 2021 · International Journal of Environmental Research and Public Health
11. Quantity of IgG response to SARS-CoV-2 spike glycoprotein predicts pulmonary recovery from COVID-19
    Manfred Nairz, Sabina Sahanic, Alex Pizzini, Anna Boehm, Piotr Tymoszuk, Anna‐Maria Mitterstiller, Laura von Raffay, Philipp Grubwieser, Rosa Bellmann‐Weiler, Sabine Koppelstätter et al. · 2022 · Scientific Reports
12. COVID-19 immunization threshold(s): an analysis
    Luis Alfredo Bautista Balbás, Mario Gil-Conesa, Blanca Bautista Balbás, Ainhoa Alcaide Jiménez, Gil Rodríguez‐Caravaca · 2021 · medRxiv
13. Broad-spectrum antiviral activity of two structurally analogous CYP3A inhibitors against pathogenic human coronaviruses in vitro
    Lara Gallucci, James Bazire, Andrew D. Davidson, Iart Luca Shytaj · 2023 · Antiviral Research
14. Differential persistence of neutralizing antibody against SARS-CoV-2 in post immunized Bangladeshi population
    Dipa Rani Roy, Md. Mosfequr Rahman, Arnaba Saha Chaity, Md Abu Reza, Ariful Haque · 2022 · Scientific Reports
15. Intrinsic factors behind long COVID: exploring the role of nucleocapsid protein in thrombosis
    Ahmed Eltayeb, Muhamed Adilović, Maryam Golzardi, Altijana Hromić-Jahjefendić, Alberto Rubio‐Casillas, Vladimir Nikolaevich Uversky, Elrashdy M Moustafa Mohamed Redwan · 2025 · PeerJ
16. Molecular Communications in Viral Infections Research: Modelling, Experimental Data and Future Directions
    Michael Taynnan Barros, Mladen Veletić, Masamitsu Kanada, Massimiliano Pierobon, Seppo Juhani Vainio, Ilangko Balasingham, Sasitharan Balasubramaniam · 2020 · Open Access at Essex (University of Essex)
17. Two Opposing Roles of SARS-CoV-2 RBD-Reactive Antibodies in Pre-Pandemic Plasma Samples From Elderly People in ACE2-Mediated Pseudovirus Infection
    Kyu-Young Sim, Gwang-Hoon Ko, So-Eun Bae, Kyu Yeong Choi, Jung Sup Lee, Byeong Chae Kim, Kun Ho Lee, Mi‐Ryoung Song, Sung‐Gyoo Park · 2022 · Frontiers in Immunology
18. Systematic evaluation of plasma signaling cascades by functional proteomics approaches: SARS‐CoV‐2 infection as model
    Pablo Juanes‐Velasco, Marina L. García‐Vaquero, Alicia Landeira‐Viñuela, José Luís López-Campos, Carmen Marín, Quentin Lécrevisse, Carlota Arias‐Hidalgo, Enrique Montalvillo, Rafael Góngora, Ángela‐Patricia Hernández et al. · 2022 · PROTEOMICS - CLINICAL APPLICATIONS
19. Broad Spectrum Antiviral Therapy can Supersede Vaccination Strategy for Combating COVID-19 Pandemic
    Ashok K. Chakraborty · 2021 · Medical Journal of Clinical Trials & Case Studies
20. An Innate Checkpoint Determines Immune Dysregulation and Immunopathology during Pulmonary Murine Coronavirus Infection
    Sarah Grabherr, Alexandra Waltenspühl, Lorina Büchler, Mechthild Lütge, Hung‐Wei Cheng, Sonja Firner, Burkhard Ludewig, Philippe Krebs, Natalia Barbara Pikor · 2023 · The Journal of Immunology
21. Review of hygiene adaptations among UK doctors in controlling the spread of SARS-CoV-2 infection
    Syed Ammar Husain, Syed Arshad Husain, Obaid U Khan, Leon Gerard D'Cruz, Victoria L Allgar · 2021 · Clinical Medicine
22. Detection of Antibodies Against the SARS-CoV-2 Spike Protein and Analysis of the Peripheral Blood Mononuclear Cell Transcriptomic Profile, 15 Years After Recovery From SARS
    Lili Zhao, Na Han, Yali Zheng, Huiying Rao, Jia Li, Yanwen Chen, Bing Yu, Yu Xu, Hongsong Chen, Zhancheng Gao et al. · 2021 · Frontiers in Cellular and Infection Microbiology
23. How Will the Covid-19 Vaccines Help Shape the Herd Immunity against Covid-19?
    T Weitao · 2021 · Virology & Immunology Journal
24. SARS-CoV-2 Antibody Testing: Important but Imperfect
    J. Stapleton · 2020 · Clinical Infectious Diseases
25. Down but far from out: The durability of SARS-CoV-2 immunity after asymptomatic infection
    Ross M. Kedl · 2021 · The Journal of Experimental Medicine
26. Innate Immune Response in Respiratory System: A Double-edged Sword Against Virus Infection
    Ang Li, Jianqing Xu · 2021 · Infectious Diseases & Immunity
27. Inflammasome-Mediated Mechanisms Of Systemic Inflammation In COVID-19 And Asthma
    Т. И. Виткина, Tatyana G. Lobova, Tamara Bogomaz, E. V. Korableva · 2024 · Russian Open Medical Journal
28. Control theory helps to resolve the measles paradox
    Anet J. N. Anelone, Edward J. Hancock, Nigel Jonathan Klein, Peter Kim, Sarah K. Spurgeon · 2021 · Royal Society Open Science
29. Family matters for coronavirus disease and vaccines
    David J. Bean, Manish Sagar · 2021 · Journal of Clinical Investigation
30. COVID-19 immunologic and toxicological implication: Innate immune sensor and immune escape
    M Luisetto, Farhan Ahmad Khan, Edbey Khaled, Gamal Abdul Hamid, Ghulam Rasool Mashori, BA Nili, C Fiazza, YesvI R, Latishev Yu O · 2021 · Archives of Pharmacy and Pharmaceutical Sciences
31. Can Facial Masking Slow Down the Spread of SARS-CoV-2 by a Variolation-like Effect?
    Fatih Şahiner · 2020 · Journal of Molecular Virology and Immunology
32. Antibody and T-cellular response to COVID-19 booster vaccine in SARS-CoV-1 survivors
    Binan Lu, Ka-Li Zhu, Xiao-Ming Cui, Yao Lin, Xuejun Wang, Guolin Wang, Li‐Jun Duan, Aruna Qian, Mai‐Juan Ma · 2022 · Clinical Immunology
33. Influenza viral particles harboring the SARS-CoV-2 spike RBD as a combination respiratory disease vaccine
    Ryan R. Chaparian, Alfred T. Harding, Kristina J. Riebe, Amelia Karlsson, Gregory D. Sempowski, Nicholas S. Heaton, Brook E. Heaton · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
34. Cytokines in Innate Immunity
    Zlatko Dembić · 2021 · Elsevier eBooks
35. Human anti-ACE2 monoclonal antibodies as pan-sarbecovirus prophylactic agents
    Fengwen Zhang, Jesse Jenkins, Robson Amparo de Carvalho, Sandra Nakandakari-Higa, Teresia Chen, Morgan E. Abernathy, Elisabeth K. Nyakatura, David P. Andrew, Irina Lebedeva, Ivo C. Lorenz et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
36. Recent Advances in Understanding COVID-19 Pathophysiology and Therapy: A Review
    Imran Rashid Rangraze, Malay Jhancy, Shehla Khan · 2023 · Preprints.org
37. MIS-C pathogenesis: immune dysregulation & viral triggers
    Tiantian Xu, Jiamin Zhang, Xiangyuan Hou, Xin-Yu Xie, Jun-Ye Qi, Changbing Wang, Yuqing Yan, Lu Kuang, Bing Zhu · 2025 · Frontiers in Immunology
38. Nasal Mucosa Exploited by SARS-CoV-2 for Replicating and Shedding during Reinfection
    Heng Li, Xin Zhao, Jing Li, Hui-Wen Zheng, Yu-Rong Zhao, Jin-Ling Yang, Jing-Xian Zhou, Fengmei Yang, Yan-Li Chen, Yuanyuan Zuo et al. · 2022 · Viruses
39. Sustained immunological memory to SARS-CoV-2 antigens. Three years of observation
    Zulfiia E. Afridonova, А. П. Топтыгина, Elena L. Semikina · 2024 · Russian Journal of Infection and Immunity
40. Deciphering long-term immune effects of HIV-1/SARS-CoV-2 co-infection: a longitudinal study
    Elena Vázquez‐Alejo, María de la Sierra Espinar-Buitrago, Esmeralda Magro-López, Laura Tarancón‐Díez, Cristina Díez, José Ignacio Bernardino, Anna Rull, Ignacio De Los Santos, Roberto Alonso, Angielys Zamora et al. · 2024 · Medical Microbiology and Immunology
41. Immunobiology and immunotherapy of COVID-19
    Kenneth H. Lundstrom · 2025 · Progress in molecular biology and translational science
42. The race to find COVID-19 Vaccine: So near, yet so far!
    Sonali Sachdeva, Udita Gupta, Anupam Prakash, Shubha Laxmi Margekar, Ritika Sud · 2020 · Indian Journal of Medical Specialities
43. Natural immune response and protection from SARS-CoV-2 reinfection
    Katia Margiotti, Marco Fabiani, Alvaro Mesoraca, Claudio Giorlandino · 2021 · Acta Virologica
44. Participación de las respuestas inmunes en el control de la COVID-19
    Cristina Pérez · 2022 · Revista Ecuatoriana de Medicina y Ciencias Biológicas
45. Preexisting vs. de novo antibodies against SARS-CoV-2 in individuals without or with virus infection: impact on antibody therapy, vaccine research and serological testing
    Kar Muthumani, Ziyang Xu, Moonsup Jeong, Joel N. Maslow, Vaniambadi S. Kalyanaraman, Alagarsamy Srinivasan · 2021 · Translational Medicine Communications
46. In Silico Design and Evaluation of a Novel Therapeutic Agent Against the Spike Protein as a Novel Treatment Strategy for COVID-19 Treatment
    Soroush Sarmadi, Mohammad Reza Rahbar, Hamideh Najafi, Onyeka S. Chukwudozie, Mohammad Hossein Morowvat · 2023 · Recent Patents on Biotechnology
47. Immunological changes in a cohort of COVID-19 survivors: Mansoura University experience
    Tamer Ali Elhadidy, Heba Wagih Abdelwahab, Doaa Abdelhalim Shahin, Asem A. Hewidy, Eman Omar Khashaba, Rehab Ahmad Elmorsey, Nermin Abo El Kheir, Elsayed A. Eid, Ahmed El‐Mesery, Marwa O. Elmaria · 2023 · F1000Research
48. Humoral and Cellular Immune Response to SARS-CoV-2 S and N Proteins
    Zulfiia E. Afridonova, А. П. Топтыгина, Ilya Sergeevich Mikhaylov · 2024 · Biochemistry (Moscow)
49. The immune response to SARS-CoV-2. Focus on severe COVID-19 pathogenesis
    Rafał Pawliczak · 2020 · Alergologia Polska - Polish Journal of Allergology
50. The quest continues for perfect COVID-19 vaccine
    Rajesh Bhatia · 2020 · The Indian Journal of Medical Research
51. Evaluation of Biochemical Test Results in Patients with COVID-19 Infection
    Marilena Stamouli, Sofia Kougioumtzidou, Antonia Mourtzikou, Antonia K Korre, Georgia Kalliora, Panagiotis Koumpouros, Maria Tsesmeli, Vasiliki Mpourtsala, Anastasios Skliris, Christos Stergiou · 2022 · European Journal of Biomedical Research
52. In the shadow of antibodies: how T cells defend against COVID-19
    David S. Pisetsky, Kevin L. Winthrop · 2022 · Annals of the Rheumatic Diseases
53. Severe Acute Respiratory Syndrome Coronavirus 2 Dynamics of Human Infection: Molecular Biology, Virology, and Immunology
    Lamech Malagho Mwapagha, James Abugri, Jeya Kennedy, Munyaradzi Zivuku, Harris Onywera · 2022 · Exploratory Research and Hypothesis in Medicine
54. GABA administration limits viral replication and pneumonitis in a mouse model of COVID-19
    Jide Tian, Blake Middleton, Daniel L. Kaufman · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
55. Epidemic trends of SARS-CoV-2 associated with immunity, race, and viral mutations
    Yasuhiko Kamikubo, Toshio Hattori, Atsushi Takahashi · 2021
56. Measles Infection Dose Responses: Insights from Mathematical Modeling
    Anet J. N. Anelone, Hannah Clapham · 2024 · Bulletin of Mathematical Biology
57. Selection and characterization of human scFvs targeting the SARS-CoV-2 nucleocapsid protein isolated from antibody libraries of COVID-19 patients
    Simonetta Lisi, Francesca Malerba, Paola Quaranta, Rita Florio, Ottavia Vitaloni, Elisa Monaca, Bruno Bruni Ercole, Angela Rachel Bitonti, Olga del Perugia, Marianna Mignanelli et al. · 2024 · Scientific Reports
58. Monoclonal antibodies: their place in applied medicine and their role in the newest infectious disease – history, present, and future. Literature review
    Petar Yordanov Atanasov, Maria Georgieva Moneva-Sakelarieva, Yozlem Ali Kobakova, Stefka Achkova Ivanova, Maria Stamova Vakrilova Becheva, Angelina Georgieva Kirkova-Bogdanova, Maria Sevdelinova Chaneva, Ventseslava Petrova Atanasova, Radoslav Fedeev Todorov, Nikolay Zarkov Bashev et al. · 2025 · Pharmacia
59. Pulmonary function and comparative SARS-CoV-2 RBD-specific IgG antibody response among the COVID-19 recovered group
    Abu Bakar Siddik, Arman Faisal, A K Azad Khan, Morshed Alam, Jannatul Nayeem, Umme Kulsum, Sharmin Aktar Mukta, Zannat Kawser, Imrul Hasan, Kasrina Azad et al. · 2025 · PLoS ONE
60. Anticoronavirus Isoquinoline Alkaloids: Unraveling the Secrets of Their Structure–Activity Relationship
    Marcela Šafratová, Yu‐Li Chen, Anna Hošťálková, Jakub Chlebek, Chung‐Fan Hsieh, Bing‐Hung Chen, Lucie Cahlíková, Štefan Kosturko, Anders Backlund, Jim‐Tong Horng et al. · 2025 · Influenza and Other Respiratory Viruses
61. COVID-19 Vaccines
    Vasantha Kamath, B. Nivea · 2021 · APIK Journal of Internal Medicine
62. Examination of Common Coronavirus Antibodies in SARS-CoV-2-Infected and Uninfected Participants in a Household Transmission Investigation
    Megan M. Stumpf, Brandi D. Freeman, Lisa A. Mills, Sandra N. Lester, Victoria T. Chu, Hannah L. Kirking, Natalie J. Thornburg, Marie E. Killerby · 2022 · Open Forum Infectious Diseases
63. Panics and pandemics
    Edward P. Rybicki · 2023 · Elsevier eBooks
64. Escalating SARS-CoV-2 specific humoral immune response in rheumatoid arthritis patients and healthy controls
    Dóra Németh, Hajnalka Vágó, László Tóthfalusi, Zsuzsanna Ulakcsai, David A Becker, Zsofia Szabo, Bernadett Rojkovich, Lilla Gunkl-Tóth, Béla Péter Merkely, György Nagy · 2024 · Frontiers in Immunology
65. Structural and functional constraints on spike activation and host protease utilization limit cell entry of SARS-CoV-2-related bat coronaviruses
    Qingqing Li, Xiao Cai, Xiaoning Li, Yi-Bing Zhang, Ru Li, Zirui Kang, Didi Wan, Jiaxu Wang, Lili Li, Junxia Yang et al. · 2025 · Journal of Virology
66. Impact of COVID-19 on Women, Pregnancy and Psychologically
    Sharleen Khan · 2020 · Indian Journal of Forensic Medicine & Toxicology
67. Vaccine against SARS-CoV-2: Challenges and considerations
    Ruchi Chaube · 2021 · Canada Communicable Disease Report
68. Immunological considerations and vaccines against COVID-19
    2021 · Biomedical Letters
69. Pandemic’s silver lining
    Fortunato Ferrara, Sara D’Angelo, M. Frank Erasmus, Andre A. R. Teixeira, Camila Leal‐Lopes, Laura P. Spector, Tom Pohl, Adeline M. Fanni, Simon Cocklin, Andrew M. Bradbury · 2022 · mAbs
70. Epidemic trends of SARS-CoV-2 associated with immunity, race, and viral mutations
    Yasuhiko Kamikubo, Toshio Hattori, Atsushi Takahashi · 2020
71. COVID-19: a review from origin to immune responses
    Arefe Vafaeinezhad, Mohammad Reza Atashzar, Rasoul Baharlou · 2022
72. Epidemic trends of SARS-CoV-2 associated with immunity, race, and viral mutations
    Yasuhiko Kamikubo, Toshio Hattori, Atsushi Takahashi · 2020
73. T-Zellantworten gegen SARS-CoV-2 und die Rolle präexistierender Gedächtniszellen
    Alexander Scheffold, Petra Bächer · 2020 · Trillium Immunologie
74. Epidemiologial Analysis of Patients Presenting to a West London District General Hospital Requiring Admission with Covid-19
    Eleanor Heald, N Ring, Dinesh Ramesh Mirpuri Vatvani, D Shackleton · 2020 · medRxiv
75. Immunologic Responses against SARS-CoV-2
    Cássio Santana Meira, Vinícius Pinto Costa Rocha, Iasmim Diniz Orge, Danielle Devequi Gomes Nunes, Emanuelle de Souza Santos, Gabriela Louise de Almeida Sampaio, Patrícia Kauanna Fonseca Damasceno, Afrânio Ferreira Evangelista, Luciana Knop, Ricardo Ribeiro dos Santos et al. · 2020 · Journal of Bioengineering, Technologies and Health
76. Immunological Approaches and Different Strategies for Vaccine Development Against SARS-COV-2
    Muhammed Babakir‐Mina · 2020 · Kurdistan Journal of Applied Research
77. Severe acute respiratory syndrome Coronavirus-2 infection: A synopsis of the host immune responses and viral immune evasion strategies involved
    N. Umar, Bala, Jibril Adamu, T. Ahmad, Muhammad, H. Ahmad, Kabiru, Ochuko Orakpoghenor, S. Aliyu, Bashir, Mohammed Nuhu, Aliyu Sada · 2021 · Novel Research in Microbiology Journal
78. Guide pratique à l’intention des laboratoires cliniques pour les tests de sérologie du SRAS-CoV-2
    au nom du groupe de travail sur la sérologie du Réseau des laboratoires de santé publique du Canada (RLSPC), Carmen L. Charlton, Jamil Kanj, Vanessa Tran, Julianne V. Kus, Jonathan B. Gubbay, Carla Osiowy, Jason Lorne Robinson, Inna Sekirov, MICHAEL A. DREBOT et al. · 2021 · Relevé des maladies transmissibles au Canada
79. COVID-19 immunity and vaccines: what a pharmacist needs to know
    Rula M. Darwish · 2021 · Asian Biomedicine
80. Risk Factors of SARS-CoV-2 and Follow-up in Patients with Common Underlying Diseases on the Dynamic Changes of Antibodies: A Cross-sectional Study
    Jin Yang, Ma Libing, Li Guo, Ting Zhang, Zhiwei Leng, Mengmeng Jia, Fangyuan Chen, Weiran Qi, Xingxing Zhang, Qing Wang et al. · 2021 · Research Square
81. COVID-19: Cross Reactive Immunity, Herd Immunity, and Convalescent Serum Therapy
    Nahla Khamis Ibrahim, Hala Abubaker Bagabir · 2021 · Journal of Pharmaceutical Research International
82. Scrutiny of human lung infection by SARS-CoV-2 and associated human immune responses in humanized mice
    Renren Sun, Zongzheng Zhao, Cong Fu, Yixin Wang, Zhendong Guo, Chunmao Zhang, Lina Liu, Cheng Zhang, Chang Shu, Jin He et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
83. The Influence of Online Learning on Learning Interest and Motivation and Their Impact on Student Achievement at Educational Technology Study Program – Ibn Khaldun University Bogor
    Mohammad Givi Efgivia, Al-Bahra Al-Bahra, Abdul Karim Halim, R. Andi Ahmad Gunadi · 2021 · Advances in Science Technology and Engineering Systems Journal
84. A review of leading COVID-19 vaccines, the quest for immune protection, and its key challenges. Part 3: Covid-19 vaccines – Key challenges and translational science
    Johan Hartshorne, Pierre J.T. De Villiers · 2021 · AfricArXiv (OSF Preprints)
85. A potential immunological silver bullet for COVID‐19: The trivalent chimpanzee adenoviral serotype‐68 vector (Tri:ChAd)
    Özge Ardıçlı, Ahmet Kürşat Azkur, Dilek Azkur · 2022 · Allergy
86. Desarrollo de inmunidad humoral en personas infectadas por SARS-COV-2
    David Eduardo Vinueza-López, Adriana Estefanía Zurita-Bombón, Maribel Jácome, Juan Alberto Viteri-Rodríguez · 2022 · Revista Arbitrada Interdisciplinaria de Ciencias de la Salud Salud y Vida
87. Technological innovation and the future of predictive model of pandemics (Preprint)
    Xavier Dupont · 2021
88. Epidemic trends of SARS-CoV-2 associated with immunity, race, and viral mutations
    Yasuhiko Kamikubo, Toshio Hattori, Atsushi Takahashi · 2021
89. РОЛЬ КЛЕТОЧНОГО ЗВЕНА ИММУНИТЕТА В ФОРМИРОВАНИИ ИММУННОГО ОТВЕТА ПРИ КОРОНАВИРУСНЫХ ИНФЕКЦИЯХ
    Ivanova Ia, N. D. Omelchenko, Anna V. Filippenko, Anastasia A. Trufanova, А. К. Носков · 2021
90. The Flow Cytometry Study of Cellular Immunity in Rhesus Monkeys after Experimental Infection with SARS CoV 2 Virus
    Galina V. Borisevich, С. Л. Кириллова, Iuliia Shatokhina, Vitaliy N. Lebedev, S. S. Solov’ev, Сыромятникова Светлана Ивановна, N. V. Shagarova, N. V. Boyarskaya, N. G. Levkovich, D. A. Solyanik et al. · 2022 · Problems of Particularly Dangerous Infections
91. Current Status of Vaccines Developed for SARS-CoV-2 Infection: A Review
    Carlos Andrés Marín Hoyos, Jean Paul Cappellaro Sánchez, Romel F Gómez, Monica Chavez Vivas · 2022 · Bangladesh Journal of Infectious Diseases
92. "SARS-CoV-2 Antibodies and Immunity: Still to Explore for COVID-19"
    Ashok K. Chakraborty · 2022 · Biomedical Journal of Scientific & Technical Research
93. Inflammatory environment in patients with COVID-19
    Ignacio Ventura · 2023 · Nereis Interdisciplinary Ibero-American Journal of Methods Modelling and Simulation
94. Data from Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy
    Roni Tamari, Ioannis Politikos, David A. Knorr, Santosha Adipudi Vardhana, Jennifer C. Young, LeeAnn T. Marcello, Sital Doddi, Sean M. Devlin, Lakshmi V. Ramanathan, Melissa S. Pessin et al. · 2023
95. COVID-19 Vaccines: Was the Writing on the Wall?
    Anna Roitburd‐Berman, Jonathan M. Gershoni · 2023 · Frontiers for Young Minds
96. Broad-spectrum antiviral activity of clinically approved CYP3A inhibitors against pathogenic human coronaviruses in vitro
    Lara Gallucci, James Bazire, Andrew D. Davidson, Iart Luca Shytaj · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
97. Exploring the long-term seroprevalence of SARS-CoV-2 antibodies in infants born to women with clinical or laboratory-confirmed COVID-19
    Uswa Jiwani, Khushboo Qaim Ali, Saleema Khowaja, Junaid Iqbal, Almas Aamir, Uzair Ansari, Muhammad Atif Habib, Sajid Bashir Soofi, Shabina Ariff · 2023 · Pediatrics & Neonatology
98. Endemic Human Coronavirus-Specific Nasal Immunoglobulin A and Serum Immunoglobulin G Dynamics in Lower Respiratory Tract Infections
    Ferdyansyah Sechan, Katherine Loens, Herman Goossens, Margareta M. Ieven, Lia van der Hoek · 2024 · Vaccines
99. COVID-19 therapy directed against pathogenic mechanisms of severe acute respiratory syndrome coronavirus 2
    Charles W. Stratton, Yi‐Wei Tang · 2024 · Elsevier eBooks
100. Developing oxygen-controlling strategies to boost vaccine immunity and understand hypoxic tumor responses
     Zachary J. Rogers · 2023 · Digital Repository Service (Northeastern University)